Search - tctmd.com

Displaying 121 - 140 of 491

Sort: Relevancy | Date

News Features

TCAR’s Rise Is Shaking Up Carotid Stenosis, but Dependable Data Lag Behind

Todd Neale

January 02, 2020

News Daily News

Counting CPCs May Beat Stress Tests for Stratifying CAD Risk

Yael L. Maxwell

December 11, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2019

Shelley Wood

November 29, 2019

News Conference News VIVA 2019

Clinicians Get Real on Radiation: ‘Don’t Do Dumb Things’

L.A. McKeown

November 07, 2019

News Conference News TCT 2019

Predicting Final Valve Position After TAVR: Different Devices, Different Success

Michael O'Riordan

October 07, 2019

News Conference News TCT 2019

No Safety Signal Seen for CTO PCI at 3 Years: EUROCTO

Yael L. Maxwell

September 29, 2019

News Conference News TCT 2019

From Ceiling Suspension to Eye-Tracking: Innovation Continues for Cath Lab Radiation Protection

Yael L. Maxwell

September 25, 2019

News Conference News ESC 2019

COMPLETE Beats Culprit-Only PCI in Multivessel STEMI and Timing Doesn’t Matter

Yael L. Maxwell

September 01, 2019

News Daily News

CT Perfusion Imaging for In-Stent Restenosis Shows Promise

Yael L. Maxwell

August 15, 2019

News Daily News

CTO PCI Consensus Document Aims for Quality, Consistency but Acknowledges Data Gaps

Yael L. Maxwell

August 08, 2019

News Daily News

FDA Grants Cardiac MR Indication for Gadavist Contrast Injection

Shelley Wood

July 16, 2019

News Conference News SCCT 2019

Sex-Specific ‘Inventory’ Needed to Spot Key CVD Risk Factors in Women

Yael L. Maxwell

July 12, 2019

News Industry News

SMT Announces CE* Mark for the Most Deliverable Stent Supraflex Cruz

July 11, 2019

News Daily News

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Michael O'Riordan

July 10, 2019

News Daily News

Rapid-Access CT Model Seeks to Increase Efficiency, Reduce Delays for Chest Pain

Yael L. Maxwell

June 21, 2019

News Daily News

Charles E. Chambers, Radiation Safety Proponent and Passionate Mentor, Dies at 64

Yael L. Maxwell

June 12, 2019

News Daily News

OVER Trial: Long-term Mortality Similar After Endovascular and Open AAA Repair

Todd Neale

May 30, 2019

News Daily News

Staged, Complete PCI Beats Culprit Stenting Out to 5 Years in STEMI Patients

Caitlin E. Cox

May 10, 2019

News Industry News

Biosense Webster Announces Initial Results From First In-Human Study Of Novel High Power-Short Duration Ablation Catheter For Atrial Fibrillation

May 09, 2019

News Industry News

FDA approves new treatments for heart disease caused by a serious rare disease, transthyretin mediated amyloidosis

May 06, 2019

Advertisement

TCAR’s Rise Is Shaking Up Carotid Stenosis, but Dependable Data Lag Behind

Counting CPCs May Beat Stress Tests for Stratifying CAD Risk

TCTMD’s Top 10 Most Popular Stories for November 2019

Clinicians Get Real on Radiation: ‘Don’t Do Dumb Things’

Predicting Final Valve Position After TAVR: Different Devices, Different Success

No Safety Signal Seen for CTO PCI at 3 Years: EUROCTO

From Ceiling Suspension to Eye-Tracking: Innovation Continues for Cath Lab Radiation Protection

COMPLETE Beats Culprit-Only PCI in Multivessel STEMI and Timing Doesn’t Matter

CT Perfusion Imaging for In-Stent Restenosis Shows Promise

CTO PCI Consensus Document Aims for Quality, Consistency but Acknowledges Data Gaps

FDA Grants Cardiac MR Indication for Gadavist Contrast Injection

Sex-Specific ‘Inventory’ Needed to Spot Key CVD Risk Factors in Women

SMT Announces CE* Mark for the Most Deliverable Stent Supraflex Cruz

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Rapid-Access CT Model Seeks to Increase Efficiency, Reduce Delays for Chest Pain

Charles E. Chambers, Radiation Safety Proponent and Passionate Mentor, Dies at 64

OVER Trial: Long-term Mortality Similar After Endovascular and Open AAA Repair

Staged, Complete PCI Beats Culprit Stenting Out to 5 Years in STEMI Patients

Biosense Webster Announces Initial Results From First In-Human Study Of Novel High Power-Short Duration Ablation Catheter For Atrial Fibrillation

FDA approves new treatments for heart disease caused by a serious rare disease, transthyretin mediated amyloidosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content